Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 125.28
+2.54 (2.07%)
Oct 7, 2026, 3:29 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.54 billion as of October 7, 2026. That makes Par Drugs and Chemicals the world's 38,725th most valuable company and 2,935th in India. Its market cap has increased by 17.58% in one year.
Market Cap
1.54B
Enterprise Value
1.12B
Revenue
1.09B
Global Rank
Country Rank
#2,935 India
PE Ratio
10.63
ChartMarket Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.54B, an increase of 396.65%. That is a compound annual growth rate of 24.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.54B | 23.72% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 10.97B |
| Bafna Pharmaceuticals | 9.14B |
| Amanta Healthcare | 7.76B |
| Valiant Laboratories | 6.77B |
| Nectar Lifesciences | 2.04B |
| Brooks Laboratories | 1.60B |
| Balaxi Pharmaceuticals | 1.26B |
| Alpa Laboratories | 1.24B |